These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 17531918)

  • 21. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
    Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
    Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of heart rate on wave reflections may be determined by the level of aortic stiffness: clinical and technical implications.
    Papaioannou TG; Vlachopoulos CV; Alexopoulos NA; Dima I; Pietri PG; Protogerou AD; Vyssoulis GG; Stefanadis CI
    Am J Hypertens; 2008 Mar; 21(3):334-40. PubMed ID: 18219305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bridge to heart transplantation with left ventricular assist device versus inotropic agents in status 1 patients.
    Sasaki H; Mitchell JD; Jessen ME; Lavingia B; Kaiser PA; Comeaux A; Dimaio JM; Meyer DM
    J Card Surg; 2009; 24(6):756-62. PubMed ID: 19754680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of right ventricular dysfunction after left ventricular assist device implantation.
    Nakatani S; Thomas JD; Savage RM; Vargo RL; Smedira NG; McCarthy PM
    Circulation; 1996 Nov; 94(9 Suppl):II216-21. PubMed ID: 8901749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
    Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
    N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive improvement in cardiac performance with continuous aortic flow augmentation (aortic flow therapy) in patients hospitalized with severe heart failure: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
    Zile MR; Colombo PC; Mehra M; Greenberg B; Brown S; Konstam MA
    J Heart Lung Transplant; 2010 Jan; 29(1):86-92. PubMed ID: 20123246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.
    Williams B; Lacy PS; Cruickshank JK; Collier D; Hughes AD; Stanton A; Thom S; Thurston H;
    Circulation; 2009 Jan; 119(1):53-61. PubMed ID: 19103995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a pulsatile pediatric ventricular assist device in an acute right heart failure model.
    Shum-Tim D; Duncan BW; Hraska V; Friehs I; Shin'oka T; Jonas RA
    Ann Thorac Surg; 1997 Nov; 64(5):1374-80. PubMed ID: 9386707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation.
    Gracin N; Johnson MR; Spokas D; Allen J; Bartlett L; Piccione W; Parrillo JE; Costanzo MR; Calvin JE
    J Heart Lung Transplant; 1998 Oct; 17(10):1017-23. PubMed ID: 9811411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular assist device malfunction: a systematic approach to diagnosis.
    Horton SC; Khodaverdian R; Powers A; Revenaugh J; Renlund DG; Moore SA; Rasmusson B; Nelson KE; Long JW
    J Am Coll Cardiol; 2004 May; 43(9):1574-83. PubMed ID: 15120814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of continuous thermodilution cardiac output in patients implanted with a left ventricular assist device.
    Mets B; Frumento RJ; Bennett-Guerrero E; Naka Y
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):727-30. PubMed ID: 12486654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular assist device outflow-graft site: effect on myocardial blood flow.
    Tuzun E; Narin C; Gregoric ID; Cohn WE; Frazier OH
    J Surg Res; 2011 Nov; 171(1):71-5. PubMed ID: 20605602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Right ventricular dysfunction after left ventricular assist device implantation].
    Ríha H; Netuka I; Kotulák T; Malý J; Pind'ák M; Kellovský P; Kopác F; Hodr D; Szarszoi O; Kettner J; Al-Hiti H; Dorazilová Z; Marek T; Skalský I; Pirk J
    Vnitr Lek; 2010 Jan; 56(1):30-6. PubMed ID: 20184109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support.
    Latif N; Yacoub MH; George R; Barton PJ; Birks EJ
    J Heart Lung Transplant; 2007 Mar; 26(3):230-5. PubMed ID: 17346624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.